Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 12, Issue 7
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Immune cell therapies and immune cell engineering
Original research
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Online download statistics by month:
Online download statistics by month: July 2024 to January 2026
Abstract
Full
Pdf
Jul 2024
784
788
300
Aug 2024
887
895
167
Sep 2024
423
427
103
Oct 2024
260
260
91
Nov 2024
205
208
97
Dec 2024
163
166
57
Jan 2025
168
169
73
Feb 2025
256
256
82
Mar 2025
165
165
81
Apr 2025
182
182
83
May 2025
162
162
63
Jun 2025
102
103
54
Jul 2025
2
2
0
Oct 2025
5
5
0
Jan 2026
0
0
1
Total
3764
3788
1252
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?